Overviewing SLEEP 2025: Thoughts and Perspectives From the President of AASM
June 19th 2025Anita Shelgikar, MD, a clinical professor at the University of Michigan and president of the American Academy of Sleep Medicine, provided post-conference perspectives on the 2025 SLEEP meeting, giving clinicians insights on the latest in research and treatment updates.
Exploring the Clinical Impact of Health and Wellness Coaching in MS Care: Cassandra Moore, MPH, CPH
June 18th 2025The associate vice president of strategy and innovation at the National MS Society highlighted the measurable benefits of health and wellness coaching for individuals with multiple sclerosis. [WATCH TIME: 5 minutes]
Bridging Sleep Science and Biomarkers in Neurodegeneration: Lea Grinberg, MD, PhD
June 17th 2025The neuropathologist at Mayo Clinic Florida discussed why EEG-based sleep biomarkers may help detect Alzheimer disease earlier and how they could enhance clinical trial design. [WATCH TIME: 3 minutes]
Using a Family-Centered Approach for Care in Pediatric Sleep Health: Funke Afolabi-Brown, MD, FAASM
June 17th 2025The chief executive officer of Restful Sleep MD emphasized the importance of tailoring pediatric sleep interventions to each family’s unique structure, values, and challenges. [WATCH TIME: 5 minutes]
Understanding Pediatric Insomnia: Risk Factors, Clinical Diagnosis, and Care Management
June 16th 2025Deepa Burman, MD, FAASM, co-director of the Pediatric Sleep Evaluation Center at UPMC Children’s Hospital of Pittsburgh, discussed the potential contributors to pediatric insomnia and the role of a thorough assessment for effective management.
Strengthening Duchenne Care Through Clinical Collaboration and Community Focus: Brenda L. Wong, MD
June 15th 2025The director of the DMD Program at UMass Chan Medical School shared her experience at the 2025 CureDuchenne FUTURES National Conference, held May 22-25, in San Antonio, Texas. [WATCH TIME: 5 minutes]
Insights on NervGen Pharma’s Positive Phase 1b/2a Data for NVG-291 in Spinal Cord Injury
June 14th 2025Daniel Mikol, MD, PhD, chief medical officer at NervGen Pharma, provided clinical perspective on recently announced positive findings from a phase 1b/2a trial testing NVG-291 as a treatment for spinal cord injury.
Looking at the Importance of Family-Centered Care Approaches in Pediatric Sleep Medicine
June 13th 2025Funke Afolabi-Brown, MD, FAASM, chief executive officer of Restful Sleep MD, discussed the potential role of family dynamics and individualized planning in the effective management of pediatric sleep disorders.
Evolving Perceptions and Care Challenges in Migraine: Michael Marmura, MD
June 13th 2025The director of outpatient care at Jefferson Headache Center reflected on advances in migraine care and the ongoing outpatient challenges in treating this widespread yet under-recognized condition. [WATCH TIME: 3 minutes]
Emerging Considerations in Peripheral Nerve Injury and Surgical Intervention: Kevin Swong, MD
June 12th 2025The neurosurgeon at Northwestern Medicine discussed diagnostic approaches, evolving treatment strategies, and the importance of timely referral in managing peripheral nerve injuries. [WATCH TIME: 3 minutes]